rac Lasofoxifene-d4 |
|
| Synonyms: rel-(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy-d4]phenyl]-2-naphthalenol; rac-(5R-cis)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy-d4] phenyl]-2-naphthalenol; | |
| Cat. No.: L15030 | CAS No.: Unlabelled:180916-16-9 |
| MDL.: | Formula: C28H27D4NO2 |
| F.W.417.58 | Purity: 99% |
| Storage: No Data Available | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 1mg | POA | Enter qty and click checkbox |
| Catalog Number： | L15030 | CAS No.: | Unlabelled:180916-16-9 | |
| MDL: | Formula: | C28H27D4NO2 | ||
| F.W.: | 417.58 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | No Data Available | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | No Data Available | Stability: | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Baumann, R., et al.: Biochem. Pharmacol., 55, 841 (1998),Ammann, P., et al.: Osteoporos Int., 10, 369 (1999), Alexandersen, P., et al.: J. Clin. Endocrinol. Metab., 86, 755 (2001), Bourrin, S., et al.: Bone, 30, 195 (2002), Buzdar, A., et al.: J. Clin. Oncol., 21, 1007 (2003), | |||
| Application: | rac Labelled Lasofoxifene. A next-generation selective estrogen receptor modulator | |||
| Category: | Aromatics, Chiral Reagents, Heterocycles, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals | |||